Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Screening and Milling of Granules for Tablets – V 2.0

Posted on By

Tablets: SOP for Screening and Milling of Granules for Tablets – V 2.0

Standard Operating Procedure for Screening and Milling of Granules for Tablets

Department Tablet
SOP No. SOP/TAB/005/2025
Supersedes SOP/TAB/005/2022
Page No. Page 1 of 8
Issue Date 05/03/2025
Effective Date 10/03/2025
Review Date 05/03/2026

1. Purpose

To outline the procedure for screening and milling granules for tablet manufacturing, ensuring uniform particle size distribution and optimal processing for the subsequent tablet compression step.

2. Scope

This SOP applies to the screening and milling of granules following granulation, including the use of sieves and mills to achieve the desired granule size and uniformity for tablet production.

3. Responsibilities

  • Manufacturing Personnel: Operate the screening and milling equipment, ensuring granules meet size specifications.
  • Quality Control (QC): Perform checks on granule size, particle uniformity, and moisture content to ensure quality standards are met.
  • Quality Assurance (QA): Oversee compliance with SOP and ensure all equipment is operating within regulatory requirements.

4. Accountability

The Production Manager is accountable for the proper operation of the screening and milling equipment. The QA Manager ensures compliance with this SOP and GMP standards.

5. Procedure

5.1 Equipment Preparation

  1. Inspect all screening and milling equipment, including sieves, mills, and any auxiliary components,
to ensure they are clean, calibrated, and in proper working condition.
  • Check that the sieves are correctly sized for the required granule particle size, and verify that milling equipment is free from residue from previous batches.
  • Ensure the area around the equipment is clean and organized to prevent cross-contamination between materials.
  • 5.2 Granule Screening

    1. Transfer the granules from the granulation process into the screening area.
    2. Place the appropriate sieve or mesh size into the screening equipment to achieve the desired particle size for the granules.
    3. Use mechanical vibration or manual agitation to pass the granules through the sieve, ensuring the larger and smaller particles are separated effectively.
    4. Discard oversized and undersized granules, and collect the properly sized granules for the next processing step.
    5. Monitor the process for uniformity, and adjust equipment settings if necessary to ensure consistency in granule size distribution.

    5.3 Granule Milling

    1. Transfer the screened granules into the milling equipment (e.g., oscillating granulator or hammer mill).
    2. Adjust the milling settings, including the mesh size of the screen or sieve used within the mill, to achieve the desired particle size.
    3. Begin milling the granules, and monitor the granule size distribution to ensure it falls within the required specifications for tablet compression.
    4. Periodically check the size of the milled granules to ensure uniformity and the desired consistency. Take samples for QC testing if necessary.
    5. Stop milling once the required granule size is achieved, and proceed with the next steps in the tablet manufacturing process.

    5.4 In-Process Quality Control

    1. After screening and milling, perform in-process checks on granule size and particle uniformity.
    2. Test a sample of the granules for moisture content using a moisture analyzer, ensuring it falls within the required specifications.
    3. Document all quality control test results and observations in the batch record and QC log (Annexure-1).
    4. If granule size or moisture content does not meet specifications, evaluate the process and make necessary adjustments to the equipment or procedure.

    5.5 Equipment Shutdown and Cleaning

    1. After completing the screening and milling process, turn off the equipment and clean the sieves, mills, and other components according to the cleaning SOP.
    2. Ensure all equipment is thoroughly cleaned to prevent contamination in future batches. Remove any leftover granules from the equipment and dispose of them according to the waste disposal procedure.
    3. Record the cleaning and maintenance activities in the equipment log to ensure traceability and compliance with GMP guidelines.

    5.6 Documentation and Record-Keeping

    1. Record all operational steps in the batch record, including equipment settings, granule sizes, and in-process checks.
    2. Document any deviations from the standard process and actions taken to correct them.
    3. Sign off on the batch record to confirm that the screening and milling process was completed in compliance with the SOP.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • GMP: Good Manufacturing Practice
    • QC: Quality Control
    • QA: Quality Assurance

    7. Documents

    1. Granule Screening and Milling Batch Record (Annexure-1)
    2. Granule Quality Control Log (Annexure-2)

    8. References

    • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
    • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
    • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Granule Screening and Milling Batch Record

    Batch Number Material Name Screening Mesh Size Milling Equipment Granule Size Moisture Content Remarks
    Batch 001 Material A 0.8 mm Oscillating Granulator 75% < 500 µm 4.5% Within Specifications
    Batch 002 Material B 1.0 mm Hammer Mill 80% < 500 µm 5.0% Minor Deviations

    Annexure-2: Granule Quality Control Log

    Batch Number Test Performed Result Test Date QC Personnel
    Batch 001 Granule Size Pass 05/03/2025 John Doe
    Batch 002 Moisture Content Pass 06/03/2025 Jane Smith

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP Creation QA Head
    01/02/2025 2.0 Updated Granule Size Specifications Standardization of Screening and Milling Process QA Head
    See also  Tablets: SOP for Preventive Action Reports (PAR) for Deviations - V 2.0
    Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

    Post navigation

    Previous Post: SOP for Safe Storage of Flammable Materials
    Next Post: SOP for Conducting Ex Vivo Studies in Preclinical Models

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version